Related Experiment Videos
Atrial fibrillation and embolic complications
1Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Ethiopia.
East African Medical Journal
|January 1, 1997
Summary
This study on cardiac patients with atrial fibrillation (AF) found rheumatic heart disease to be a major cause of embolic episodes. Anticoagulation is recommended for high-risk AF patients to prevent systemic emboli.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Atrial fibrillation (AF) is a common cardiac arrhythmia associated with an increased risk of systemic embolization.
- Rheumatic heart disease (RHD) is a significant cause of morbidity and mortality worldwide, particularly in developing countries.
- Understanding the specific risk factors and outcomes of AF in different patient populations is crucial for effective management.
Purpose of the Study:
- To analyze the clinical characteristics and embolic complications in a cohort of cardiac patients with atrial fibrillation (AF).
- To identify the primary causes of embolization in this AF patient group.
- To provide recommendations for anticoagulation therapy to mitigate embolic risk.
Main Methods:
- Retrospective analysis of clinical records from 136 cardiac patients with AF at Black Lion Hospital.
- Data collected included patient demographics, underlying cardiac conditions, and incidence of embolic events.
- Statistical analysis was performed to determine the prevalence of different heart diseases and causes of embolization.
Main Results:
- The study included 136 patients with a mean age of 41 years; females were more prevalent (1.0:1.6 male to female ratio).
- Rheumatic heart disease (RHD) was the predominant underlying condition (66.3%), followed by hypertension (10.3%).
- Embolic episodes occurred in 19.1% of patients, with cerebrovascular accidents (21 cases) and femoral artery occlusion (5 cases) being the main manifestations. Rheumatic valvular heart diseases, especially mitral stenosis, were the leading cause of embolization (65.5%).
Conclusions:
- Rheumatic heart disease is a major risk factor for systemic embolization in patients with atrial fibrillation.
- A significant proportion of AF patients experienced embolic events, highlighting the need for effective preventive strategies.
- Anticoagulation is strongly recommended for AF patients with recent congestive heart failure, prior thromboembolism, or hypertension, provided no contraindications exist.